Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis

NCT03389893 · clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
72
Enrollment
NIH
Sponsor class

Stopped Due to inability to meet accrual goals within the funding period.

Conditions

Interventions

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators